Bothrops disintegrin and disintegrin-like domain

Bothrops disintegrins and disintegrin-like domains are a family of non-enzymatic, cysteine-rich polypeptides found in the venom of Bothrops species, commonly known as lancehead pit vipers. These molecules are primarily known for their ability to bind with high affinity to integrin receptors on the surface of platelets and other cell types, effectively blocking the binding of adhesive glycoproteins such as fibrinogen (PMID: 11514225). This interaction results in the potent inhibition of platelet aggregation and the disruption of cell-matrix adhesion, which are key factors in the hemorrhagic pathology observed during Bothrops envenomation (PMID: 21539941). Disintegrin-like domains are also found as part of larger Snake Venom Metalloproteinases (SVMPs), where they contribute to the targeting and localized activity of the enzyme (UniProt P22103). Beyond their toxicological role, these domains have been instrumental in cardiovascular research, serving as the structural templates for the development of clinically used antiplatelet drugs like eptifibatide. Furthermore, they are being investigated for potential therapeutic applications in oncology due to their ability to inhibit angiogenesis and tumor metastasis by interfering with integrin-mediated signaling (PMID: 15507183). They typically contain a conserved Arg-Gly-Asp (RGD) motif that mimics the binding sites of endogenous ligands. Their high specificity for particular integrin subtypes makes them valuable tools for studying cell surface receptor function. In clinical settings, the primary interaction with drugs occurs through antivenoms that neutralize these toxins during envenomation. Overall, they represent a significant class of venom components with both pathological impact and pharmacological potential.

Other names

Snake venom disintegrinSVMP disintegrin-like domainRGD-containing venom proteinBothropic disintegrinDisintegrin-like domain-containing snake venom metalloproteinase

Bothrops disintegrins and disintegrin-like domains act as potent, competitive antagonists of various integrin receptors, most notably the platelet-specific alpha-IIb/beta-3 (GPIIb/IIIa) receptor, as well as alpha-v/beta-3 and alpha-5/beta-1 (PMID: 11514225). They typically contain a conserved Arg-Gly-Asp (RGD) or similar motif (e.g., KGD, MLD) within a flexible loop, which mimics the binding sequence of endogenous ligands like fibrinogen, fibronectin, and von Willebrand factor (PMID: 21539941). By binding to these receptors, they prevent ligand-mediated cell signaling and physical cross-linking, leading to the inhibition of platelet aggregation and the disruption of cell-extracellular matrix adhesion (PMID: 15507183).